Pfizer Manufacturing Deutschland GmbH is awarded the HCPC Alliance Columbus trophy for compliance enhancing packaging design 2011.
At Fleming Europe's Pharma packaging & labelling compliance conference 2011, which took place in Barcelona on March 23rd and 24th, the HCPC Alliance¹ presented for the first time the Columbus Award for compliance enhancing packaging design. Innovative packaging solutions with elements to help patients to take their medications as prescribed were presented and the Columbus Award was given to the solution that, according to the jury, offered the most comprehensive support.
The Champix/Chantix wallet packaging portfolio, from Pfizer Manufacturing Deutschland GmbH is an answer to the question how to enhance compliance for products marketed on a global scale by customized packaging solutions. It provides a multi-dimensional solution for the essential product medication scheme, regional packaging requirements but also important prescription and reimbursement regulations.
Compliance delivered through an innovative packaging platform is a critical success factor due to the treatment regime:
• Patients needs to set a date to stop smoking
• Begin of treatment one week before that date
• Titration dose (day 1-3 0,5 mg once a day, day 4-7 0,5 mg twice a day, continuing weeks 1 mg twice daily for a total of 12 weeks).
The above story is reprinted from materials provided by http://www.hcpc-europe.net/.